Supernus Pharmaceuticals, Inc. Financial Ratios — SUPN Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	-141.65	-202.72	-29.46	21.67	65.21	24.95	30.81	21.57	18.94	6.85	7.13	0.15	7.55	-3.68
Return on Assets (%)	106.84	-62.66	-90.03	-8.82	8.57	36.62	15.61	15.83	10.58	9.53	3.35	3.58	0.09	5.58	-2.73
Return on Capital (%)	- -	- -	- -	- -	22.83	- -	25.11	23.87	14.86	13.58	5.87	5.27	0.21	7.27	- -
Return on Invested Capital (%)	- -	- -	- -	- -	24.56	- -	24.09	21.62	13.03	12.51	4.88	3.58	0.56	5.67	- -
Gross Margin (%)	100	100	90.81	93.79	94.29	94.43	94.97	96.24	95.76	89.92	87.05	86.93	86.21	88.23	89.63
EBITDA Margin (%)	-4,591.91	-2,790.41	-509.01	-4.69	14.76	26.33	35.63	37.05	39.52	37.23	19.33	19.66	16.17	23.57	7.61
Operating Margin (%)	-4,701.37	-2,849.26	-515.18	-5.69	14.13	25.22	32.93	35.33	37.83	33.74	13.71	6.84	2.21	11.42	-5.13
Incremental Operating Margin (%)	- -	- -	- -	- -	47.68	49.41	51.96	42.1	-25.57	21.17	-161.84	-38.74	53.94	114.47	- -
Pretax Margin (%)	-4,915.32	-3,127.3	-767.73	-11.11	9.91	23.43	33.29	34.28	37.55	32.41	12.62	9.1	0.46	14.79	-6.82
Profit Margin (%)	6,701.74	-3,127.3	-767.73	-11.79	9.46	42.43	18.95	27.14	28.79	24.39	9.21	9.1	0.22	11.16	-5.36
Net Income to Common Margin (%)	6,274.6	-3,204.53	-767.73	-11.79	9.46	42.43	18.95	27.14	28.79	24.39	9.21	9.1	0.22	11.16	-5.36
Effective Tax Rate (%)	- -	- -	- -	- -	4.56	- -	43.07	20.82	23.35	24.72	26.99	0.05	52.47	24.53	- -
Dvd Payout Ratio (%)	12.87	2.41	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	-138.24	-202.72	-29.46	21.67	65.21	24.95	30.81	21.57	18.94	6.85	7.13	0.15	7.55	-3.68

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	29	23	34	26	7	4	- -	329	378	414	427	445	42	34	41
ST Debt	7	12	- -	- -	- -	- -	- -	- -	3	4	6	409	8	7	11
LT Debt	23	11	34	26	7	4	- -	329	376	411	421	36	33	27	30
Total Debt/EBITDA	-0.8	-0.55	-0.56	-6.03	0.33	0.07	- -	2.17	2.44	2.14	3.81	3.39	0.42	0.22	0.75
Net Debt/EBITDA	0.52	0.42	-0.02	2.34	-1.21	-1.1	-0.93	0.91	1.06	0.38	1.57	2.35	-0.76	-0.44	-2.35
Total Debt/EBIT	-0.78	-0.54	-0.56	-4.97	0.34	0.08	- -	2.28	2.55	2.36	5.37	9.75	3.1	0.45	-1.11
Net Debt/EBIT	0.5	0.41	-0.02	1.93	-1.27	-1.15	-1.01	0.95	1.1	0.42	2.21	6.77	-5.6	-0.92	3.48
EBITDA to Interest Expense	-19.76	-11.55	-7.79	-0.77	4.56	11.12	68.67	8.37	6.84	8.16	4.79	18.55	40.69	- -	- -
EBITDA-CapEx/Interest Expense	-20.13	-11.76	-8.09	-0.88	4.12	10.81	67.38	8.32	6.78	8	4.7	18.49	40.46	- -	- -
EBIT to Interest Expense	-20.23	-11.8	-7.89	-0.94	4.37	10.65	63.48	7.98	6.54	7.39	3.39	6.45	5.55	- -	- -
Interest Expense	2	4	8	6	5	5	2	18	23	24	23	7	2	- -	- -
Common Equity/Total Assets	17.48	61.25	30.15	29.75	46.66	61.94	63.02	46.33	51.32	49.52	48.3	52.05	72.12	75.71	73.09
Long-Term Debt/Equity (%)	240.51	19.26	102.78	64.43	8.05	2.17	- -	72.73	63.08	55.12	51.55	4.06	3.6	2.64	2.86
Long-Term Debt/Capital (%)	58.34	13.78	50.68	39.18	7.45	2.13	- -	42.1	38.57	35.42	33.84	2.7	3.45	2.56	2.75
Long-Term Debt/Total Assets (%)	42.27	11.8	30.99	19.17	3.76	1.35	- -	33.69	32.37	27.3	24.9	2.11	2.6	2	2.09
Total Debt/Equity (%)	312.25	39.77	102.78	64.43	8.05	2.17	- -	72.73	63.56	55.62	52.34	50.19	4.51	3.31	3.86
Total Debt/Capital (%)	75.74	28.46	50.68	39.18	7.45	2.13	- -	42.1	38.86	35.74	34.36	33.42	4.31	3.2	3.72
Total Debt/Total Assets (%)	54.88	24.36	30.99	19.17	3.76	1.35	- -	33.69	32.62	27.55	25.28	26.12	3.25	2.51	2.82
Net Debt to Equity	-201.82	-30.23	4.22	-25	-30.01	-32.45	-37.5	30.29	27.51	9.82	21.55	34.85	-8.14	-6.69	-12.1
Net Debt/Capital (%)	198.21	-43.33	4.05	-33.33	-42.88	-48.05	-60	23.25	20.67	8.4	16.91	24.95	-8.45	-6.93	-13.18
EBITDA	-37	-41	-61	-4	22	57	108	152	155	194	112	131	98	156	55
EBITDA-CapEx	-38	-42	-64	-5	20	55	106	151	154	190	110	131	98	155	53
Operating Income (Loss)	-38	-42	-62	-5	21	54	100	144	149	176	79	46	13	76	-37

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.59	3.85	3.11	2.64	1.09	1.12	1.14	2.21	2.16	1.72	1.08	0.67	0.88	1.55	0.91
Current Ratio	2.63	3.98	3.68	3.87	1.86	1.88	1.86	3.06	2.94	2.57	1.91	1.07	1.7	2.35	1.9
Quick Ratio	2.59	3.88	3.3	3.26	1.55	1.63	1.67	2.84	2.71	2.3	1.55	0.91	1.38	2.04	1.47
CFO/Avg Current Liab	-2.13	-2.26	-2.35	-0.9	0.81	0.97	1.13	0.91	0.89	0.68	0.45	0.23	0.23	0.59	0.15
Common Equity/Total Assets	17.48	61.25	30.15	29.75	46.66	61.94	63.02	46.33	51.32	49.52	48.3	52.05	72.12	75.71	73.09
Long-Term Debt/Equity (%)	240.51	19.26	102.78	64.43	8.05	2.17	- -	72.73	63.08	55.12	51.55	4.06	3.6	2.64	2.86
Long-Term Debt/Capital (%)	58.34	13.78	50.68	39.18	7.45	2.13	- -	42.1	38.57	35.42	33.84	2.7	3.45	2.56	2.75
Long-Term Debt/Total Assets (%)	42.27	11.8	30.99	19.17	3.76	1.35	- -	33.69	32.37	27.3	24.9	2.11	2.6	2	2.09
Total Debt/Equity (%)	312.25	39.77	102.78	64.43	8.05	2.17	- -	72.73	63.56	55.62	52.34	50.19	4.51	3.31	3.86
Total Debt/Capital (%)	75.74	28.46	50.68	39.18	7.45	2.13	- -	42.1	38.86	35.74	34.36	33.42	4.31	3.2	3.72
Total Debt/Total Assets (%)	54.88	24.36	30.99	19.17	3.76	1.35	- -	33.69	32.62	27.55	25.28	26.12	3.25	2.51	2.82
CFO/Total Liabilities	-81.71	-129.6	-74.74	-25.49	34.31	56.71	73.03	24.58	25.34	18.23	14.56	14.31	31.19	51.74	12.11
CFO/CapEx	-52.82	-62.68	-24.65	-41.31	16.41	41.68	56.5	152.83	103.19	37.51	62.16	283.56	201.61	237.17	35.37
Altman's Z-Score	-2.71	1.73	-0.92	1.54	4.08	7.75	9.67	3.47	2.68	2.95	3.25	3.17	5.47	6.6	6.61

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	36.5	269.09	4.75	8.3	6.83	6.38	5.64	4.85	4.13	4.56	4	4.24	3.92	4.62	4.36
Days Sales Outstanding	10	1.36	76.91	43.96	53.44	57.24	64.68	75.21	88.4	80.03	91.23	86	93.02	78.93	83.74
Inventory Turnover	- -	- -	0.27	0.56	0.65	0.82	0.92	0.73	0.64	1.4	1.12	0.98	0.99	1.18	1.09
Days Inventory Outstanding	- -	- -	1,372.72	652.7	563.95	447.46	397.09	498.71	572.77	260.75	326.49	371.4	368.03	308.52	334.54
Accounts Payable Turnover	- -	0.1	1.03	4.81	2.45	2.62	1.98	4.92	2.64	9.11	14.56	9.34	11.14	16.73	28.26
Accounts Payable Turnover Days	- -	3,553.21	354.72	75.82	148.94	139.34	184.74	74.14	138.06	40.09	25.07	39.08	32.77	21.82	12.91
Cash Conversion Cycle	- -	- -	1,094.9	620.84	468.44	365.36	277.02	499.78	523.12	300.7	392.65	418.32	428.28	365.63	405.36
Inventory to Cash Days	- -	- -	-1,295.81	-608.74	-510.51	-390.22	-332.41	-423.5	-484.37	-180.72	-235.27	-285.4	-275.01	-229.59	-250.8
Inventories	- -	1	7	13	13	17	16	26	27	48	86	92	77	54	82
Raw Materials	- -	1	4	2	3	2	3	6	5	22	7	25	16	11	32
Work In Process	- -	- -	1	6	4	9	9	7	11	9	46	32	31	27	29
Finished Goods	- -	- -	2	5	6	6	4	13	11	17	33	35	30	16	21
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	220	301	357	659	1,262	2,045	1,738	1,246	1,330	1,553	1,935	1,584	2,016	2,856
- Cash & Cash Equivalents	49	40	33	36	33	66	100	192	181	289	203	93	75	69	128
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	29	23	34	26	7	4	- -	329	378	414	427	445	42	34	41
Enterprise Value	-19	154	254	309	604	1,176	1,905	1,711	1,277	1,322	1,640	1,919	1,370	1,596	2,588
Total Capital	39	80	68	67	95	196	267	782	974	1,159	1,243	1,331	963	1,070	1,103
Total Debt/Capital (%)	75.74	28.46	50.68	39.18	7.45	2.13	- -	42.1	38.86	35.74	34.36	33.42	4.31	3.2	3.72
Total Debt / EV	-1.55	0.15	0.14	0.08	0.01	- -	- -	0.19	0.3	0.31	0.26	0.23	0.03	0.02	0.02
EV/Sales	- -	104.02	21.11	3.33	4.09	5.47	6.3	4.19	3.25	2.54	2.83	2.88	2.26	2.41	3.6
EV/EBITDA	- -	- -	- -	- -	27.73	20.77	17.69	11.3	8.23	6.82	14.63	14.63	13.95	10.23	47.31
EV/EBIT	- -	- -	- -	- -	28.95	21.69	19.14	11.85	8.6	7.53	20.63	42.06	102.24	21.13	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	15.44	15.46	16.49	11.94	7.96	8.46	11.37	15.49	12.21	9.28	54.68
EV/Free Cash Flow to Firm	- -	- -	- -	- -	14.66	15.15	16.2	11.87	7.89	8.26	11.21	15.44	12.15	9.24	53.17
Diluted Market Cap	- -	125	240	420	688	1,306	2,124	1,797	1,277	1,351	1,585	2,200	1,606	2,023	2,806
Diluted Enterprise Value	-19	108	242	410	661	1,243	2,024	1,934	1,474	1,477	1,809	2,552	1,573	1,988	2,718
EV per Share	- -	5.03	6.34	7.18	12.32	23.53	37.12	32.71	24.32	25	30.8	35.36	25.04	28.64	45.04
TTM Sales	1	1	12	93	147	215	302	409	393	520	580	667	608	662	719
TTM EBITDA	-37	-41	-61	-4	22	57	108	152	155	194	112	131	98	156	55
TTM Operating Income	-38	-42	-62	-5	21	54	100	144	149	176	79	46	13	76	-37
TTM Cash Flow to Firm	-35	-44	-50	-19	39	76	116	143	161	156	144	124	112	172	47
TTM Free Cash Flow to Firm	-34	-43	-48	-18	41	78	118	144	162	160	146	124	113	173	49

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	-2.69	-4.32	-17.57	18.77	19.08	18.21	13.84	8.83	9.51	12.27	18.77	14.39	11.72	57.65
EV/EBIT	- -	- -	- -	- -	28.95	21.69	19.14	11.85	8.6	7.53	20.63	42.06	102.24	21.13	- -
Enterprise Value	-19	154	254	309	604	1,176	1,905	1,711	1,277	1,322	1,640	1,919	1,370	1,596	2,588
Low Price	- -	4.3	4.45	7.09	7.97	9.51	23.1	30.05	19.35	13.12	23.15	24.95	21.99	25.53	29.16
EV/Sales	- -	104.02	21.11	3.33	4.09	5.47	6.3	4.19	3.25	2.54	2.83	2.88	2.26	2.41	3.6
EV/EBITDA	- -	- -	- -	- -	27.73	20.77	17.69	11.3	8.23	6.82	14.63	14.63	13.95	10.23	47.31
Price/Earnings	- -	- -	- -	- -	45.77	13.69	35.31	15.56	11	10.43	28.98	31.53	1,199.3	26.97	- -
Price/Earnings Average	- -	-3.65	-2.31	-34.37	49.37	10.3	32.19	21.8	14.49	9.05	28.78	27.99	1,349.59	23.36	-57.42
Price/Earnings High	- -	-6.13	-3.12	-44.37	79.35	14.7	44.34	28.69	19.96	11.42	34.29	33.94	1,744.25	29.37	-84.42
Price/Earnings Low	- -	-1.58	-1.54	-27.43	27.13	5.16	20.47	14.08	8.97	5.44	23.01	22.05	911.29	19.04	-42.7
Price/Book Value	- -	3.81	9.01	8.76	7.48	6.58	7.65	3.84	2.09	1.79	1.9	2.18	1.72	1.95	2.69
Price/Book Value Average	- -	5.28	7.98	9.38	8.07	4.95	6.97	5.37	2.76	1.55	1.89	1.94	1.93	1.69	2.12
Price/Book Value High	- -	8.87	10.81	12.11	12.97	7.06	9.6	7.07	3.8	1.96	2.25	2.35	2.5	2.12	3.12
Price/Book Value Low	- -	2.29	5.32	7.49	4.44	2.48	4.43	3.47	1.71	0.93	1.51	1.53	1.31	1.37	1.58
Price/Tangible Book Value	- -	3.86	9.33	8.81	7.57	8.12	8.83	4.12	2.18	4.4	-17.98	29	7.74	5.08	7.77
Price/Tangible Book Value Average	- -	5.34	8.27	9.43	8.16	6.11	8.06	5.77	2.88	3.82	-17.86	25.75	8.71	4.4	6.13
Price/Tangible Book Value High	- -	8.98	11.2	12.18	13.12	8.71	11.09	7.6	3.96	4.81	-21.28	31.22	11.26	5.53	9.02
Price/Tangible Book Value Low	- -	2.31	5.51	7.53	4.49	3.06	5.12	3.73	1.78	2.29	-14.28	20.29	5.88	3.59	4.56
Price/Sales	- -	84.49	19.98	3.78	4.33	5.81	6.69	4.22	3.17	2.54	2.67	2.87	2.6	3.01	3.9
Price/Sales Average	- -	116.95	17.7	4.05	4.67	4.37	6.1	5.92	4.17	2.21	2.65	2.55	2.92	2.61	3.08
Price/Sales High	- -	196.56	23.98	5.23	7.5	6.24	8.4	7.79	5.74	2.79	3.16	3.09	3.78	3.28	4.53
Price/Sales Low	- -	50.67	11.79	3.23	2.57	2.19	3.88	3.82	2.58	1.33	2.12	2.01	1.97	2.13	2.29
Price/Cash Flow	- -	-2.65	-4.14	-14.32	18.49	18.7	17.64	13.39	8.69	9.57	12.18	16.39	14.21	11.59	59.28
Price/Cash Flow Average	- -	-3.67	-3.67	-15.33	19.94	14.07	16.09	18.76	11.45	8.3	12.09	14.55	15.99	10.04	46.76
Price/Cash Flow High	- -	-6.16	-4.97	-19.79	32.05	20.07	22.16	24.69	15.76	10.48	14.41	17.64	20.66	12.62	68.76
Price/Cash Flow Low	- -	-1.59	-2.45	-12.23	10.96	7.04	10.23	12.11	7.09	4.99	9.67	11.46	10.8	8.18	34.78
Price/Free Cash Flow Average	- -	-3.73	-3.83	-18.8	20.25	14.36	16.6	19.39	11.64	8.25	12.18	16.66	16.19	10.15	45.48
Price/Free Cash Flow High	- -	-6.26	-5.18	-24.27	32.55	20.48	22.86	25.52	16.03	10.41	14.52	20.2	20.93	12.76	66.87
Price/Free Cash Flow Low	- -	-1.61	-2.55	-15	11.13	7.19	10.55	12.52	7.21	4.96	9.74	13.13	10.93	8.27	33.82
EV/Sales Average	- -	193.57	22.34	4.01	4.64	4.13	5.84	6.29	4.68	2.46	3.05	3.1	2.88	2.59	3.01
EV/Sales High	- -	333.36	30.22	5.21	7.56	6.01	8.16	8.17	6.26	3.04	3.55	3.65	3.74	3.26	4.49
EV/Sales Low	- -	77.21	14.92	3.18	2.47	1.92	3.59	4.18	3.09	1.57	2.51	2.56	1.93	2.1	2.21
EV/EBITDA Average	0.52	-6.94	-4.39	-85.43	31.43	15.67	16.38	16.98	11.85	6.61	15.75	15.78	17.8	10.97	39.59
EV/EBITDA High	0.52	-11.95	-5.94	-110.98	51.25	22.82	22.92	22.06	15.84	8.17	18.39	18.57	23.1	13.85	58.96
EV/EBITDA Low	0.52	-2.77	-2.93	-67.71	16.73	7.29	10.08	11.28	7.82	4.23	12.99	13	11.91	8.9	29.03
EV/EBIT Average	0.5	-6.79	-4.34	-70.41	32.81	16.36	17.72	17.81	12.38	7.29	22.21	45.38	130.47	22.64	-58.74
EV/EBIT High	0.5	-11.7	-5.87	-91.46	53.51	23.83	24.79	23.13	16.55	9.01	25.92	53.38	169.35	28.58	-87.48
EV/EBIT Low	0.5	-2.71	-2.9	-55.8	17.47	7.62	10.9	11.83	8.17	4.67	18.32	37.38	87.28	18.37	-43.08
Last Price	- -	7.17	7.54	8.3	13.44	25.25	39.85	33.22	23.72	25.16	29.16	35.67	28.94	36.16	49.7
High Price	- -	16.68	9.05	11.47	23.3	27.1	50.04	61.25	43.05	27.55	34.5	38.4	42.09	39.37	57.65
Enterprise Value Average	-19	286	268	372	684	887	1,764	2,572	1,840	1,280	1,766	2,070	1,749	1,711	2,165
Enterprise Value High	-19	493	363	483	1,115	1,292	2,468	3,342	2,459	1,582	2,061	2,435	2,270	2,160	3,225
Enterprise Value Low	-19	114	179	295	364	413	1,085	1,709	1,214	819	1,456	1,705	1,170	1,388	1,588

Shares Outstanding	24	31	40	43	49	50	51	52	53	53	53	54	55	56	57
Diluted Weighted Avg Shares	14	17	32	51	51	52	53	54	54	54	54	62	56	56	56
Basic Weighted Avg Shares	14	17	32	42	47	49	51	52	52	53	53	54	55	55	56
Revenue per Share	0.06	0.08	0.38	2.19	3.11	4.35	5.95	7.86	7.49	9.89	10.92	12.43	11.14	12.01	12.74
EBITDA per Share	-2.66	-2.37	-1.92	-0.1	0.46	1.14	2.12	2.91	2.96	3.68	2.11	2.44	1.8	2.83	0.97
Operating Income per Share	-2.72	-2.42	-1.94	-0.12	0.44	1.1	1.96	2.78	2.83	3.34	1.5	0.85	0.25	1.37	-0.65
Basic EPS, GAAP	3.64	-2.72	-2.9	-0.26	0.29	1.84	1.13	2.13	2.16	2.41	1.01	1.13	0.02	1.34	-0.68
Basic EPS from Cont Ops	-1.68	-2.65	-2.9	-0.26	0.29	1.84	1.13	2.13	2.16	2.41	1.01	1.13	0.02	1.34	-0.68
Diluted EPS, GAAP	3.64	-2.72	-2.9	-0.22	0.27	1.76	1.07	2.05	2.1	2.36	0.98	0.98	0.02	1.32	-0.68
Diluted EPS from Cont Ops	-1.68	-2.65	-2.9	-0.22	0.27	1.76	1.07	2.05	2.1	2.36	0.98	0.98	0.02	1.32	-0.68
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-2.61	-2.71	-1.82	-0.58	0.73	1.35	2.26	2.48	2.73	2.63	2.39	2.18	2.04	3.12	0.84
Free Cash Flow per Basic Share	-2.66	-2.75	-1.89	-0.59	0.68	1.32	2.22	2.46	2.7	2.56	2.36	2.17	2.03	3.11	0.81
Cash & Equivalents per Share	2.03	2.89	2.06	1.73	1.27	1.8	2.73	6.81	6.61	7.99	6.38	8.5	4.66	8.14	5.37
Book Value per Share	0.39	1.88	0.84	0.95	1.8	3.84	5.21	8.66	11.33	14.09	15.32	16.33	16.84	18.58	18.48
Tangible Book Value per Share	0.35	1.86	0.81	0.94	1.78	3.11	4.51	8.06	10.86	5.72	-1.62	1.23	3.74	7.12	6.39

Supernus Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)